General Information
Revision date
2016-11-29
Product name
Dactinomycin for Injection
Product Synonyms
• Actinomycin D for Injection
1.2.1 Relevant identified uses
• Pharmaceutical for human use. Cancer therapeutic agent
Manufacturer Name
Recordati Rare Diseases Inc. (RRD)
Emergency telephone
1-(800) 424-9300
Icons in SDS
Company Information
company name
Recordati Rare Diseases Inc. (RRD)
e-mail address of the competent person responsible for the Safety Data Sheet
info@recordatirarediseases.com
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H301
Hazard statements
Code
Statements
H301
Toxic if swallowed
Section 2
SECTION 2: Hazards identification
OSHA HCS 2012 United States (US)
Prevention
Wash thoroughly after handling Do not eat, drink or smoke when using this product.
Response
IF SWALLOWED Immediately call a POISON CENTER/doctor Specific treatment, see supplemental first aid information. Rinse mouth. Storage/Disposal • Store at controlled room temperature of 20-25°C (68-77°F) according to Package Labeling instructions. Protect from heat, light and moisture. Storage consistent with chemotherapeutic pharmaceutical agents, such as secondary containment to minimize risk of spill or breakage, is appropriate. Dispose of content and/or container in accordance with local, regional, national, and/or international regulations.
2.1 Classification of the substance or mixture
Classification of the substance or mixture OSHA HCS 2012 • Acute Toxicity Oral 3
